At SK pharmteco, we are committed to sparking waves of change by delivering customer-focused solutions for the pharmaceutical and biopharmaceutical industries. With a global network of cGMP facilities in key strategic locations, we empower our clients to bring therapies to the patients they serve. Want to learn more? We'll be at CPHI Milan and Alliance for Regenerative Medicine's 2024 Cell & Gene Meeting on the Mesa next week talking about how we deliver life-impacting therapies. Stop by our booths: ?????????????? ???? ?????? ???????? Phoenix, AZ October 7-9, 2024? Booth #: F13 ???????? Milan, Italy? October 8-10, 2024 Booth #: 5D33 in hall 5 See you there!??? Book a meeting: https://lnkd.in/eAQgsr73 #CPHIMilan #Pharma #Biopharma #CGMesa24 #CellandGeneTherapy #CDMO #networking
关于我们
Headquartered in Rancho Cordova, California, SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. Built on 80 years of experience, our global operations have the capability and capacity to support client needs from development through commercial production. SK pharmteco is owned by SK Inc., the strategic investment arm of South Korea’s SK Group.
- 网站
-
https://www.skpharmteco.com
SK pharmteco的外部链接
- 所属行业
- 制药业
- 规模
- 1,001-5,000 人
- 总部
- Rancho Cordova ,California
- 类型
- 私人持股
- 领域
- HPAPI、High Potency API、Energetic Chemistry、Continuous Flow Process、Controlled Substances、Particle Engineering、Simulated Moving Bed Technology、Fine Chemicals、Intermediates、Analytical Services、API、Drug Development、Research & Development、Contract Manufacturing、Tech Transfer、Registered Starting Materials、Biologics、Antibody Conjugates (linkers & payloads) 、Chromatography、Analytical Services、Cell and Gene Therapy、CDMO和viral vector
地点
SK pharmteco员工
动态
-
Change is in the air... ? At SK pharmteco, we believe transformation is the foundation of progress. Stay tuned as we continue to inspire waves of change—embracing what’s next while building on the excellence that defines us. ? #CDMO #pharmainnovation #cgt #smallmolecules #analyticaltesting
-
Want to learn more about our cell and gene therapy capabilities? Dive into SK pharmteco’s Capacity Update to explore how we’re driving innovation in the #advancedtherapy space with: ?? Expanded global manufacturing capacity ?? Advanced technologies for CGT production ??A commitment to accelerating timelines and reducing cost of goods without compromising quality This is your chance to see how SK pharmteco is shaping the future of therapies that change lives. Watch now: https://lnkd.in/euFjtccR Outsourced Pharma #celltherapy #genetherapy #CDMO?
-
Get ready for BOS Manchester! Meet us there next week on November 26-27 in Manchester, UK for insights into the latest industry innovations. Book a meeting with SK pharmteco’s Anne Jan Leenhouts and Rachel Pearce to see how we can tackle your next CDMO challenge. Schedule a meeting here: https://lnkd.in/eW3jqUQT Bio2Business Ltd #BOSManchester24 #CDMO #pharmaceuticalmanufacturing
-
In case you missed it—our latest capacity update is now available to watch on demand!?SK pharmteco’s Capacity Update dives into our advancements in small molecule manufacturing, highlighting how we’re meeting industry demand through: ??Expanded production capabilities ?? Cutting-edge technologies ??Scalable global capacity supporting your program from clinical development to commercialization Whether you’re focused on APIs, intermediates, or specialized manufacturing, this webinar provides valuable insights into our commitment to excellence and innovation. Watch the full webinar here: https://lnkd.in/eJSasyzs Outsourced Pharma #smallmolecules #APIs #CDMO #analyticaltesting
-
New SK pharmteco Poster Alert: "?????????????????????? ???? ?? ??????????????????, ????????-??????????, ???????????? ???????????? ???????? ???????? ?????? ?????? ?????????????????????????? ???? ??????????-???????????????????? ??????????, ??????????- ?????? ???????????????????? ??????????????". In cell and gene therapy, HEK293 cells are a cornerstone, but ensuring scalability and compliance with CGMP standards is key. This innovative poster showcases how our experts developed an in-house and universal cell line to ensure: ??CGMP Readiness: Built for manufacturing environments, our cell line meets stringent industry regulations, enhancing consistency and reliability. ??Efficiency and Consistency: Streamlined production processes, ideal for high-quality vector production at commercial scale. ??Cost-effectiveness: Designed to reduce production costs while maintaining high yield and quality, making advanced therapies more accessible. Read more here: https://lnkd.in/dPUN_6JA
-
Catch us in San Diego next week for the Biomanufacturing World Summit November 19-21st! Be sure to connect with SK pharmteco's Jennifer Boulton, William Maggs, and John Lee to learn how we are changing the landscape in biomanufacturing. See you there! Book a meeting with one of our experts: https://lnkd.in/eUxcYj_7 ? #BiomanufacturingWorldSummit #CDMO
-
What a great time at BIO Europe 2024 last week! Thank you to everyone who stopped by the SK pharmteco booth # 177A. From engaging with other innovators in the #biopharma space, to learning about new technologies, to exploring potential partnerships, every conversation reaffirmed the momentum our field is gaining. Can’t wait for next year! #BIOEurope #celltherapy #genetherapy
-
At SK pharmteco, we pause today to honor and thank all veterans for their courage, sacrifice, and dedication. To our veteran employees, your service and commitment inspire us daily and bring invaluable strengths to our team. To the families who support them, thank you for the sacrifices you make in support of your loved ones. Today, we recognize and are profoundly grateful to all who have served to protect our freedoms.
-
Join us at the Advanced Therapies Congress USA next week, November 12-13 in Philadelphia, PA! Stop by our booth # 421 to connect with SK pharmteco’s Mark Maxwell, David Sapirstein, and?Pavle Matak, Ph.D. to learn more about the latest in innovative therapies. Don’t miss out on the chance to connect with industry leaders and explore groundbreaking solutions. See you there! #ATCongressUS